These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1295 related items for PubMed ID: 20200382

  • 1. Comparison of dopamine and norepinephrine in the treatment of shock.
    De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, SOAP II Investigators.
    N Engl J Med; 2010 Mar 04; 362(9):779-89. PubMed ID: 20200382
    [Abstract] [Full Text] [Related]

  • 2. Dopamine versus norepinephrine in the treatment of shock.
    Nathan Coxford R, Lang E, Dowling S.
    CJEM; 2011 Nov 04; 13(6):395-7. PubMed ID: 22436478
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP, Grahe JS, Sperry M, Singla S, Elpern E, Lateef O, Balk RA.
    Shock; 2010 Apr 04; 33(4):375-80. PubMed ID: 19851126
    [Abstract] [Full Text] [Related]

  • 4. Vasopressor therapy in critically ill patients with shock.
    Russell JA.
    Intensive Care Med; 2019 Nov 04; 45(11):1503-1517. PubMed ID: 31646370
    [Abstract] [Full Text] [Related]

  • 5. Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients.
    Russell JA, Vincent JL, Kjølbye AL, Olsson H, Blemings A, Spapen H, Carl P, Laterre PF, Grundemar L.
    Crit Care; 2017 Aug 15; 21(1):213. PubMed ID: 28807037
    [Abstract] [Full Text] [Related]

  • 6. Vasopressin versus norepinephrine infusion in patients with septic shock.
    Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST Investigators.
    N Engl J Med; 2008 Feb 28; 358(9):877-87. PubMed ID: 18305265
    [Abstract] [Full Text] [Related]

  • 7. Comparison of dopamine and norepinephrine in shock.
    Romero CM.
    N Engl J Med; 2010 Jun 17; 362(24):2328; author reply 2330-1. PubMed ID: 20554990
    [No Abstract] [Full Text] [Related]

  • 8. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.
    Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, Troché G, Ricard JD, Nitenberg G, Papazian L, Azoulay E, Bellissant E, CATS Study Group.
    Lancet; 2007 Aug 25; 370(9588):676-84. PubMed ID: 17720019
    [Abstract] [Full Text] [Related]

  • 9. Treating shock--old drugs, new ideas.
    Levy JH.
    N Engl J Med; 2010 Mar 04; 362(9):841-3. PubMed ID: 20200389
    [No Abstract] [Full Text] [Related]

  • 10. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.
    Pharmacotherapy; 2004 Aug 04; 24(8):1002-12. PubMed ID: 15338849
    [Abstract] [Full Text] [Related]

  • 11. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
    Russell JA, Lee T, Singer J, De Backer D, Annane D.
    J Crit Care; 2018 Oct 04; 47():333-337. PubMed ID: 29958734
    [Abstract] [Full Text] [Related]

  • 12. Controversies regarding choice of vasopressor therapy for management of septic shock in animals.
    Silverstein DC, Beer KA.
    J Vet Emerg Crit Care (San Antonio); 2015 Oct 04; 25(1):48-54. PubMed ID: 25655726
    [Abstract] [Full Text] [Related]

  • 13. Double-Blind Randomized Clinical Trial Comparing Dopamine and Epinephrine in Pediatric Fluid-Refractory Hypotensive Septic Shock.
    Ramaswamy KN, Singhi S, Jayashree M, Bansal A, Nallasamy K.
    Pediatr Crit Care Med; 2016 Nov 04; 17(11):e502-e512. PubMed ID: 27673385
    [Abstract] [Full Text] [Related]

  • 14. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
    Jia L, Wang P, Li C, Xie J.
    Shock; 2023 Dec 01; 60(6):746-752. PubMed ID: 37548686
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ, Cadiz ML, Natavio AM.
    Ann Pharmacother; 2020 Mar 01; 54(3):213-218. PubMed ID: 31625395
    [Abstract] [Full Text] [Related]

  • 16. Effect of norepinephrine on the outcome of septic shock.
    Martin C, Viviand X, Leone M, Thirion X.
    Crit Care Med; 2000 Aug 01; 28(8):2758-65. PubMed ID: 10966247
    [Abstract] [Full Text] [Related]

  • 17. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
    Vasu TS, Cavallazzi R, Hirani A, Kaplan G, Leiby B, Marik PE.
    J Intensive Care Med; 2012 Aug 01; 27(3):172-8. PubMed ID: 21436167
    [Abstract] [Full Text] [Related]

  • 18. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC, Portuguese Community-Acquired Sepsis Study Group.
    Crit Care Med; 2009 Feb 01; 37(2):410-6. PubMed ID: 19114885
    [Abstract] [Full Text] [Related]

  • 19. Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock.
    Na SJ, Yang JH, Ko RE, Chung CR, Cho YH, Choi KH, Kim D, Park TK, Lee JM, Song YB, Choi JO, Hahn JY, Choi SH, Gwon HC.
    PLoS One; 2022 Feb 01; 17(11):e0277087. PubMed ID: 36327286
    [Abstract] [Full Text] [Related]

  • 20. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
    Svoboda P, Scheer P, Kantorová I, Doubek J, Dudra J, Radvan M, Radvanova J.
    Hepatogastroenterology; 2012 Jun 01; 59(116):1043-7. PubMed ID: 22580654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.